Karin Fijnvandraat
Karin Fijnvandraat
Professor of Pediatric Hematology, Emma Childrens Hospital, Amsterdam UMC
Verified email at - Homepage
Cited by
Cited by
Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans
A Borchiellini, K Fijnvandraat, JW ten Cate, D Pajkrt, SJ Van Deventer, ...
Randomized trial of platelet-transfusion thresholds in neonates
A Curley, SJ Stanworth, K Willoughby, SF Fustolo-Gunnink, V Venkatesh, ...
New England Journal of Medicine 380 (3), 242-251, 2019
von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation
JA van Mourik, R Boertjes, IA Huisveld, K Fijnvandraat, D Pajkrt, ...
Blood, The Journal of the American Society of Hematology 94 (1), 179-185, 1999
Factor VIII inhibitors in mild and moderate-severity haemophilia A
CRM Hay, CA Ludlam, BT Colvin, FGH Hill, FE Preston, N Wasseem, ...
Thrombosis and haemostasis 79 (04), 762-766, 1998
Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality
K Fijnvandraat, B Derkx, M Peters, R Bijlmer, A Sturk, MH Prins, ...
Thrombosis and haemostasis 73 (01), 015-020, 1995
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
CL Eckhardt, AS Van Velzen, M Peters, J Astermark, PP Brons, ...
Blood, The Journal of the American Society of Hematology 122 (11), 1954-1962, 2013
The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial
J Howard, M Malfroy, C Llewelyn, L Choo, R Hodge, T Johnson, S Purohit, ...
The Lancet 381 (9870), 930-938, 2013
Non‐genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report
J Astermark, C Altisent, A Batorova, MJ Diniz, A Gringeri, PA Holme, ...
Haemophilia 16 (5), 747-766, 2010
Intensive peri-operative use of factor VIII and the Arg593→ Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A
CL Eckhardt, LA Menke, CH Van Ommen, JH Van der Lee, RB Geskus, ...
Journal of Thrombosis and haemostasis 7 (6), 930-937, 2009
Inter‐individual variation in half‐life of infused recombinant factor VIII is related to pre‐infusion von Willebrand factor antigen levels
K Fijnvandraat, M Peters, JW Ten Cate
British journal of haematology 91 (2), 474-476, 1995
Diagnosis and management of haemophilia
K Fijnvandraat, MH Cnossen, FWG Leebeek, M Peters
Bmj 344, 2012
Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease
EM de Wee, YV Sanders, EP Mauser-Bunschoten, JG van der Bom, ...
Thrombosis and haemostasis 108 (10), 683-692, 2012
Recombinant, B-domain deleted factor VIII (r-VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients
K Fijnvandraat, E Berntorp, JW Ten Cate, H Johnsson, M Peters, ...
Thrombosis and haemostasis 77 (02), 298-302, 1997
Obesity: a new disaster for haemophilic patients? A nationwide survey
FG Hofstede, K Fijnvandraat, I Plug, PW Kamphuisen, FR Rosendaal, ...
Haemophilia 14 (5), 1035-1038, 2008
von Willebrand disease and aging: an evolving phenotype
YV Sanders, MA Giezenaar, BAP Laros‐van Gorkom, K Meijer, ...
Journal of Thrombosis and Haemostasis 12 (7), 1066-1075, 2014
Neurocognitive deficits in children with sickle cell disease: a comprehensive profile
CT Hijmans, K Fijnvandraat, MA Grootenhuis, N van Geloven, H Heijboer, ...
Pediatric blood & cancer 56 (5), 783-788, 2011
Growth and nutritional status of children with homozygous sickle cell disease
AWM Al-Saqladi, R Cipolotti, K Fijnvandraat, BJ Brabin
Annals of tropical paediatrics 28 (3), 165-189, 2008
Reduced prevalence of arterial thrombosis in von Willebrand disease
YV Sanders, J Eikenboom, EM de Wee, JG van der Bom, MH Cnossen, ...
Journal of Thrombosis and Haemostasis 11 (5), 845-854, 2013
Thrombocytopenia in neonatal sepsis: Incidence, severity and risk factors
IMC Ree, SF Fustolo-Gunnink, V Bekker, KJ Fijnvandraat, SJ Steggerda, ...
PloS one 12 (10), e0185581, 2017
Quality of life of female caregivers of children with sickle cell disease: a survey
XW Van den Tweel, J Hatzmann, E Ensink, JH van der Lee, M Peters, ...
haematologica 93 (4), 588-593, 2008
The system can't perform the operation now. Try again later.
Articles 1–20